Skip to main content
Top
Published in: International Journal of Diabetes in Developing Countries 1/2015

01-03-2015 | Editorial

Sleeping well and on time—a prevention and prescription for diabetes?

Author: Krishna G. Seshadri

Published in: International Journal of Diabetes in Developing Countries | Issue 1/2015

Login to get access

Excerpt

In this issue of the journal, a study from Turkey shows that subjects with type 2 diabetes admitted in hospital had significant sleep disturbances as measured by Pittsburgh Sleep Quality Index. Depression was observed to be associated with sleep disorders in most of them [1]. …
Literature
1.
go back to reference Ücel SÇ, Güler EK, ipek A. Investigation of sleep quality, quality of life, anxiety and depression in patients with diabetes mellitus. Intl J Diab Dev Cntr. 2015. doi:10.1007/s13410-014-0206-y. Ücel SÇ, Güler EK, ipek A. Investigation of sleep quality, quality of life, anxiety and depression in patients with diabetes mellitus. Intl J Diab Dev Cntr. 2015. doi:10.​1007/​s13410-014-0206-y.
2.
go back to reference Xie L, Kang H, Xu Q, et al. Sleep drives metabolite clearance from the adult brain. Science. 2013;342:373–77.CrossRefPubMed Xie L, Kang H, Xu Q, et al. Sleep drives metabolite clearance from the adult brain. Science. 2013;342:373–77.CrossRefPubMed
4.
go back to reference Cappuccio FP, D’Elia L, Strazzullo P, et al. Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2010;33:414–20.CrossRefPubMedCentralPubMed Cappuccio FP, D’Elia L, Strazzullo P, et al. Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2010;33:414–20.CrossRefPubMedCentralPubMed
5.
go back to reference Reutrakul S, Van Cauter E. Interactions between sleep, circadian function and glucose metabolism: implications for risk and severity of diabetes. Ann NY Acad Sci. 2014;1311:151–73.CrossRefPubMed Reutrakul S, Van Cauter E. Interactions between sleep, circadian function and glucose metabolism: implications for risk and severity of diabetes. Ann NY Acad Sci. 2014;1311:151–73.CrossRefPubMed
7.
go back to reference Pan A, Schernhammer ES, Sun Q, et al. Rotating night shift work and risk of type 2 diabetes: two prospective cohort studies in women. PLoS Med. 2011;8:e1001141.CrossRefPubMedCentralPubMed Pan A, Schernhammer ES, Sun Q, et al. Rotating night shift work and risk of type 2 diabetes: two prospective cohort studies in women. PLoS Med. 2011;8:e1001141.CrossRefPubMedCentralPubMed
8.
go back to reference Merikanto I, Lahti T, Puolijoki H, et al. Associations of chronotype and sleep with cardiovascular diseases and type 2 diabetes. Chronobiol Int. 2013;30:470–7.CrossRefPubMed Merikanto I, Lahti T, Puolijoki H, et al. Associations of chronotype and sleep with cardiovascular diseases and type 2 diabetes. Chronobiol Int. 2013;30:470–7.CrossRefPubMed
9.
go back to reference Woon PY, Kaisaki PJ, Braganca J, et al. Aryl hydrocarbon receptor nuclear translocator-like (BMAL1) is associated with susceptibility to hypertension and type 2 diabetes. Proc Natl Acad Sci U S A. 2007;104:14412–7.CrossRefPubMedCentralPubMed Woon PY, Kaisaki PJ, Braganca J, et al. Aryl hydrocarbon receptor nuclear translocator-like (BMAL1) is associated with susceptibility to hypertension and type 2 diabetes. Proc Natl Acad Sci U S A. 2007;104:14412–7.CrossRefPubMedCentralPubMed
10.
go back to reference Buxton OM, Cain SW, O’Connor SP, Porter JH, Duffy JF, Wang W, et al. Adverse metabolic consequences in humans of prolonged sleep restriction combined with circadian disruption. Sci Transl Med. 2012;4:129ra43.CrossRefPubMedCentralPubMed Buxton OM, Cain SW, O’Connor SP, Porter JH, Duffy JF, Wang W, et al. Adverse metabolic consequences in humans of prolonged sleep restriction combined with circadian disruption. Sci Transl Med. 2012;4:129ra43.CrossRefPubMedCentralPubMed
Metadata
Title
Sleeping well and on time—a prevention and prescription for diabetes?
Author
Krishna G. Seshadri
Publication date
01-03-2015
Publisher
Springer India
Published in
International Journal of Diabetes in Developing Countries / Issue 1/2015
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-015-0341-0

Other articles of this Issue 1/2015

International Journal of Diabetes in Developing Countries 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.